When should low-dose aspirin (81 mg) be restarted after total knee replacement surgery?

When to Restart Aspirin After Total Knee Replacement

Restart aspirin 81 mg on the same day as surgery if it was discontinued, or continue it throughout the perioperative period without interruption. 1

Primary Recommendation

The most recent and highest-quality guideline evidence (2018 French Working Group on Perioperative Haemostasis) provides clear direction: aspirin should be resumed as early as possible after the invasive procedure, ideally the same day, according to the risk of postoperative bleeding 1. This represents the optimal balance between preventing thrombotic complications and managing bleeding risk.

Clinical Context and Rationale

For Patients Already on Aspirin for Cardiovascular Indications

• Aspirin should ideally be continued perioperatively without interruption 1
• If aspirin must be stopped preoperatively, restart it on the day of surgery once hemostasis is adequate
• The thrombotic risk of discontinuing aspirin in patients with cardiovascular disease outweighs the bleeding risk in most orthopedic procedures

For Patients Using Aspirin Solely for VTE Prophylaxis

Recent high-quality research demonstrates that:

• 81 mg aspirin once daily is effective and safe for VTE prophylaxis after total knee replacement 2, 3
• The 2026 EPCAT III trial showed aspirin alone (81 mg daily) was non-inferior to rivaroxaban followed by aspirin for preventing symptomatic VTE 2
• A large institutional study of 8,073 patients confirmed 81 mg once daily has an acceptable VTE rate (1.1% overall) 3

Start aspirin 81 mg once daily on postoperative day 1 and continue for 9 days after total knee arthroplasty (based on the EPCAT III protocol) 2

Dosing Specifics

• Dose: 81 mg once daily 2, 3
• Once-daily dosing is non-inferior to twice-daily dosing given aspirin's long-lasting effect on platelet function 3
• The older AAOS recommendation of 325 mg twice daily lacks evidence and increases GI side effects 4

Critical Timing Considerations

Same-Day Restart Algorithm:

1. Assess surgical hemostasis - ensure no active bleeding from surgical site
2. Check drain output - if <50 mL/hour, safe to restart
3. Verify hemoglobin stability - no ongoing bleeding requiring transfusion
4. Administer first dose - evening of surgery day if above criteria met

If Hemostasis Concerns Exist:

• Delay until postoperative day 1
• Do not delay beyond 24 hours unless major bleeding complications present
• The thrombotic risk increases significantly with each day of delay 1

Common Pitfalls to Avoid

1. Do not use higher doses unnecessarily - 81 mg is as effective as higher doses with fewer GI complications 3
2. Do not delay restart beyond 24 hours - increases VTE risk without meaningful bleeding benefit
3. Do not confuse VTE prophylaxis duration with cardiovascular indication - patients on aspirin for cardiac reasons need indefinite continuation
4. Do not combine with NSAIDs - significantly increases bleeding risk 1

Special Populations

Patients on Dual Antiplatelet Therapy (DAPT):

• Aspirin should continue perioperatively 1
• P2Y12 inhibitors should resume within 24-72 hours postoperatively 1
• Coordinate with cardiology for patients with recent stents (<6 months)

High-Risk Patients:

• Patients with Elixhauser Comorbidity Index >5 may benefit from more potent anticoagulation 3
• Consider risk stratification tools to identify patients needing stronger prophylaxis 5

Duration of Therapy

• For VTE prophylaxis after TKA: 9 days total 2
• For cardiovascular indications: continue indefinitely (not stopped for surgery)
• Mechanical prophylaxis (compression devices, early mobilization) should complement pharmacologic therapy throughout hospitalization